Workflow
Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates

Gilead Sciences (GILD) came out with quarterly earnings of 2.47pershare,beatingtheZacksConsensusEstimateof2.47 per share, beating the Zacks Consensus Estimate of 2.15 per share. This compares to earnings of 2.02pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof+14.882.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.88%. A quarter ago, it was expected that this HIV and hepatitis C drugmaker would post earnings of 1.95 per share when it actually produced earnings of $2.01, delivering a surprise of +3.08%.Over the last four ...